Wells Fargo initiated coverage on Amicus Therapeutics with a new price target
$FOLD
Biotechnology: Pharmaceutical Preparations
Health Care
Wells Fargo initiated coverage of Amicus Therapeutics with a rating of Overweight and set a new price target of $18.00